Corvis Corp (CORV)

Trade CORV now with
6/24/2019 7:01:54 AM Correvio Resubmits Brinavess NDA To FDA For Treatment Of Patients With Recent Onset Atrial Fibrillation
5/8/2019 8:04:46 AM Correvio Q1 Net Loss $9.0 Mln Or $0.23/Shr Vs Net Loss Of $8.5 Mln Or $0.24/Shr Last Year
4/3/2019 9:29:44 AM Correvio Announces Xydalba Abstracts At ECCMID 2019
3/14/2019 7:05:27 AM Correvio Pharma Announces At The Market Offering
3/13/2019 7:04:08 AM Correvio Pharma Q4 Net Loss $6.4 Mln Or $0.18 /Shr Vs Loss Of $8.3 Mln Or $0.24/Shr Last Year
1/2/2019 8:07:11 AM Correvio Pharma Names Mark Corrigan Next CEO To Succeed William Hunter
1/2/2019 8:05:01 AM Correvio : Mark H.N. Corrigan To Succeed William Hunter, As CEO By End Of Q1 2019
9/5/2018 7:08:18 AM Correvio Pharma Reports Preliminary Data From SPECTRUM Study
9/5/2018 7:03:25 AM Correvio Reports Preliminary Data Collected From BrinavessĀ® Treatment In EU Post-Authorization Safety Study
8/14/2018 4:05:26 PM Correvio Pharma Q2 EPS $0.16 Vs. Loss $0.26 Year Ago
6/11/2018 8:09:04 AM Correvio Pharma Provides U.S. Regulatory Update For BRINAVESS